13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 92 holding rows worth $6,230,450,000.
- Accession
- 0001104659-21-106386
- Filer
- CIK 1346824
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 92 entries on the cover page, a total value of $6,230,450,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,230,450,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 6,806,341 | $895,374,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 2,559,918 | $543,496,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 9,011,651 | $224,300,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 8,670,644 | $216,333,000 | thousands by filing date | |
| VOR BIOPHARMA INC | 929033108 | COM | 11,120,973 | $207,406,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 8,263,982 | $188,667,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 5,605,129 | $177,627,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 5,943,594 | $159,645,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 6,991,003 | $136,534,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,342,743 | $129,665,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 18,417,458 | $121,371,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 5,368,451 | $115,314,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 4,417,259 | $113,303,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 4,965,588 | $113,066,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,655,447 | $111,676,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 3,115,008 | $105,443,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 4,870,793 | $94,104,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,107,149 | $93,326,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 4,965,769 | $92,860,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 5,283,976 | $91,307,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 3,865,808 | $87,019,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 3,593,052 | $83,646,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 2,698,369 | $82,921,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 5,614,428 | $81,915,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 4,291,881 | $74,850,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 4,871,067 | $71,077,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 3,247,117 | $69,488,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 2,978,955 | $64,733,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,150,404 | $60,168,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,805,045 | $59,018,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,710,265 | $58,423,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 10,874,613 | $57,635,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 7,140,091 | $57,621,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 2,200,000 | $56,364,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,613,623 | $55,749,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 12,315,213 | $54,064,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,742,186 | $53,816,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 880,284 | $53,037,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,377,569 | $52,127,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 7,775,207 | $51,783,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 5,290,481 | $51,318,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 5,014,687 | $49,094,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 3,496,639 | $46,820,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,930,322 | $46,251,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 6,077,294 | $46,066,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 12,367,873 | $45,266,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,186,636 | $43,492,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 30,126,299 | $42,478,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 5,914,252 | $41,695,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 977,503 | $40,126,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,378,325 | $36,769,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,003,653 | $34,142,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 5,100,000 | $33,354,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,589,904 | $31,571,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 2,281,249 | $28,630,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,280,300 | $28,435,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 914,094 | $26,820,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 2,471,430 | $24,961,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,500,000 | $22,155,000 | thousands by filing date | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 2,731,170 | $16,687,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,515,151 | $14,879,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 1,250,000 | $14,225,000 | thousands by filing date | |
| ENTERA BIO LTD | M40527109 | SHS | 2,353,000 | $14,071,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 1,250,000 | $13,163,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 3,033,603 | $12,802,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 5,947,861 | $12,550,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,246,503 | $12,356,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 1,098,318 | $11,284,000 | thousands by filing date | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 1,250,000 | $11,238,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 1,000,000 | $10,720,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 750,000 | $10,635,000 | thousands by filing date | |
| PHASEBIO PHARMACEUTICALS INC | 717224109 | COM | 2,850,000 | $10,602,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 750,000 | $10,530,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 584,000 | $10,331,000 | thousands by filing date | |
| FRAZIER LIFESCIENCES ACQU CORP UNIT EXP 120925 | G3710A121 | Stock | 1,000,000 | $10,050,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 1,000,000 | $9,980,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 7,812,500 | $9,297,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 350,000 | $9,013,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,025,641 | $8,318,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 500,000 | $7,805,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 275,000 | $7,700,000 | thousands by filing date | |
| 5 01 ACQUISITION CORP | 33836P105 | CMN | 750,000 | $7,478,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 700,000 | $7,245,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 625,000 | $6,375,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 312,328 | $5,712,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 900,000 | $4,905,000 | thousands by filing date | |
| AERPIO PHARMACEUTICALS INC | 00810B105 | COM | 2,693,309 | $4,552,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 233,333 | $3,358,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 15,000 | $2,429,000 | thousands by filing date | |
| IMARA INC | 45249V107 | COM | 248,804 | $1,966,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 5,105,547 | $1,900,000 | thousands by filing date | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 62,217 | $580,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-106386 | this filing | 2021-08-16 | acceptance time not in the bulk data set |